Key references: Altitude illness

  • Beidleman BA, Tighiouart H, Schmid CH, Fulco CS, Muza SR. Predictive models of acute mountain sickness after rapid ascent to various altitudes. Med Sci Sports Exerc 2013;45(4):792-800. https://www.ncbi.nlm.nih.gov/pubmed/23135373
  • Church BJ, Basnyat B, Mattingly B, Zafren K. Pediatric High Altitude Cerebral Edema in the Nepal Himalayas. Wilderness Environ Med 2019;30(3):306-9. https://www.ncbi.nlm.nih.gov/pubmed/31301992
  • Gertsch JH, Lipman GS, Holck PS, Merritt A, Mulcahy A, Fisher RS, et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ Med 2010;21(3):236-43. https://www.ncbi.nlm.nih.gov/pubmed/20832701
  • Hackett PH, Oelz O. The Lake Louise Consensus on the definition and quantification of altitude illness. In: Sutton JR, Coates G, Houston CS. Hypoxia and mountain medicine: Proceedings of the 7th International Hypoxia Symposium, held at Lake Louise, Canada, February 1991. New York: Pergamon Press; 1992. p. 327-30.
  • Harris NS, Wenzel RP, Thomas SH. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med 2003;24(4):383-7. https://www.ncbi.nlm.nih.gov/pubmed/12745039
  • Institute for Altitude Medicine. Altitude illness web page. Telluride, CO; 2016-2018 (Accessed August 2021).
  • Irons HR, Salas RN, Bhai SF, Gregorie WD, Harris NS. Prospective Double-Blinded Randomized Field-Based Clinical Trial of Metoclopramide and Ibuprofen for the Treatment of High Altitude Headache and Acute Mountain Sickness. Wilderness Environ Med 2020;31(1):38-43. https://www.ncbi.nlm.nih.gov/pubmed/32057631
  • Kayser B, Dumont L, Lysakowski C, Combescure C, Haller G, Tramer MR. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. High Alt Med Biol 2012;13(2):82-92. https://www.ncbi.nlm.nih.gov/pubmed/22724610
  • Luks AM, Auerbach PS, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update. Wilderness Environ Med 2019;30(4S):S3-S18. https://www.ncbi.nlm.nih.gov/pubmed/31248818
  • Luks AM, Swenson ER. Travel to high altitude with pre-existing lung disease. Eur Respir J 2007;29(4):770-92. https://www.ncbi.nlm.nih.gov/pubmed/17400877
  • Luks AM, Swenson ER, Bartsch P. Acute high-altitude sickness. Eur Respir Rev 2017;26(143). https://www.ncbi.nlm.nih.gov/pubmed/28143879
  • Parise I. Travelling safely to places at high altitude - Understanding and preventing altitude illness. Aust Fam Physician 2017;46(6):380-4. https://www.ncbi.nlm.nih.gov/pubmed/28609593
  • Roach RC, Hackett PH, Oelz O, Bartsch P, Luks AM, MacInnis MJ, et al. The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol 2018;19(1):4-6. https://www.ncbi.nlm.nih.gov/pubmed/29583031
  • Shah TJ, Moshirfar M, Hoopes PC, Sr. "Doctor, I have a Sulfa Allergy": Clarifying the Myths of Cross-Reactivity. Ophthalmol Ther 2018;7(2):211-5. https://www.ncbi.nlm.nih.gov/pubmed/29959752